Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Med Intensiva (Engl Ed) ; 43(6): 337-345, 2019.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-29789184

RESUMO

BACKGROUND: Strategies for cardio-protection are essential in coronary artery bypass graft surgery. The authors explored the relationship between cardioplegia volume, left ventricular mass index and ischemia time by means of the infused cardioplegia index and its relationship with post-operative low cardiac output syndrome. DESIGN: All patients undergoing coronary artery bypass graft surgery between January 2013 and December 2015 were included. Low cardiac output syndrome was defined according to criteria of the SEMICYUC's consensus document. The perioperative factors associated with low cardiac output syndrome were estimated, and using a ROC curve, the optimum cut-off point for the infused cardioplegia index to predict the absence of low cardiac output syndrome was calculated. RESULTS: Of 360 patients included, 116 (32%) developed low cardiac output syndrome. The independent risk predictors were: New York Heart Association Functional Classification (OR 1.8 [95% CI=1.18-2.55]), left ventricle ejection fraction (OR 0.95 (95% CI=0.93-0.98]), ICI (OR 0.99 [95% CI=0.991-0.996]) and retrograde cardioplegia (OR 1.2 [95% CI=1.03-1.50]). The infused cardioplegia index showed an area under the ROC curve of 0.77 (0.70-0.83; P<.001) for the absence of postoperative low cardiac output syndrome using the optimum cut-off point of 23.6ml·min-1(100g/m2 of LV)-1. CONCLUSIONS: The infused cardioplegia index presents an inverse relationship with the development of post-operative low cardiac output syndrome. This index could form part of new strategies aimed at optimising cardio-protection. The total volume of intermittent cardioplegia, especially that of maintenance, should probably be individualised, adjusting for ischemia time and left ventricle mass index.


Assuntos
Baixo Débito Cardíaco/epidemiologia , Soluções Cardioplégicas/administração & dosagem , Ponte de Artéria Coronária , Complicações Pós-Operatórias/epidemiologia , Idoso , Baixo Débito Cardíaco/prevenção & controle , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/prevenção & controle , Estudos Prospectivos
2.
Rev Esp Cardiol ; 50 Suppl 4: 74-6, 1997.
Artigo em Espanhol | MEDLINE | ID: mdl-9411592

RESUMO

Left ventricular hypertrophy associated with systemic hypertension differs from left ventricular hypertrophy initiated by other pressure overload diseases. Its development depends not only of hemodynamics aspects but of biochemical factors. Many studies have demonstrated a close link between left ventricular hypertrophy and cardiovascular morbidity and mortality. For that reason the idea of reversal of left ventricular hypertrophy has been a goal of the antihypertensive treatment. From the literature review has been established that the most classes of antihypertensive medications reduce the left ventricular mass, though there is a variation in required duration of treatment. At this point the angiotensin converting enzyme inhibitors, probably because a double effect: hypotensive and blockers of the trophic stimulus of angiotensin II, seemed to be the most potent for reducing the left ventricular mass. Still we don't know if reversal of left ventricular hypertrophy, by the antihypertensive treatment, reduce independently the cardiovascular risk.


Assuntos
Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Hipertensão/complicações , Hipertrofia Ventricular Esquerda/etiologia , Angiotensina II , Anti-Hipertensivos/uso terapêutico , Hemodinâmica/efeitos dos fármacos , Humanos , Hipertensão/tratamento farmacológico , Hipertensão/terapia , Hipertrofia Ventricular Esquerda/mortalidade , Hipertrofia Ventricular Esquerda/prevenção & controle
3.
Rev Esp Cardiol ; 43(3): 198-200, 1990 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-2333406

RESUMO

We present a case of acute myocardial infarction in a 22 year old cocaine user. The absence of coronary artery stenotic lesions, as was seen in the coronary arteriography, and the absence of personal past cardiovascular or family history, suggest a cocaine-induced coronary spasm as responsible for the acute myocardial event.


Assuntos
Cocaína , Infarto do Miocárdio/induzido quimicamente , Transtornos Relacionados ao Uso de Substâncias/complicações , Adulto , Humanos , Masculino
4.
Rev Esp Cardiol ; 53(11): 1541-4, 2000 Nov.
Artigo em Espanhol | MEDLINE | ID: mdl-11084013

RESUMO

We report the case of a 15-year-old female, with no previous medical history, who presented cardiac tamponade secondary to purulent pericarditis caused by Neisseria meningitidis serogroup C. This microorganism is the etiologic agent in 6-16% of the cases of purulent pericarditis, most in association with previous or concomitant central nervous system involvement (meningitis). Exceptionally, as in this case, the pericarditis is not accompanied by meningitis (Primary Meningococcal Pericarditis). The patient was treated with antibiotics, pericardiocentesis and steroids with excellent response. It is important to point out that meningococcal disease may present in unusual forms which may lead to diagnostic and therapeutics difficulties.


Assuntos
Infecções Meningocócicas , Neisseria meningitidis/classificação , Pericardite/microbiologia , Adolescente , Feminino , Humanos , Sorotipagem
5.
Rev Esp Cardiol ; 46(10): 674-6, 1993 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-8235004

RESUMO

Thrombolytic therapy has shown to be effective in acute myocardial infarction, and its benefits on left ventricular function and later survival are well known. However it is not a therapy free of complications and side effects. Allergic reactions, anafilaxia, hypotension, and several kinds of hemorrhages have been reported. Adult respiratory distress syndrome after streptokinase administration has been also described, and one case, recently communicated, after APSAC therapy. We present the case of a male with acute myocardial infarction who developed adult respiratory distress syndrome after APSAC therapy, with different outcome than the first case published in the literature. Finally, we discussed the mechanisms by means these drugs can produce such a complication.


Assuntos
Anistreplase/efeitos adversos , Infarto do Miocárdio/complicações , Síndrome do Desconforto Respiratório/induzido quimicamente , Terapia Trombolítica/efeitos adversos , Adulto , Humanos , Masculino , Infarto do Miocárdio/tratamento farmacológico , Síndrome do Desconforto Respiratório/diagnóstico , Fatores de Tempo
6.
Rev Esp Cardiol ; 52(4): 277-8, 1999 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-10217971

RESUMO

We present the case of a male patient with aortic and mitral valve bioprostheses who developed infectious endocarditis due to Staphylococcus capitis, which has recently been described as an agent producing infectious endocarditis in native and prosthetic cardiac valves. The patient's course evolved unfavorably, despite specific antibiotic treatment, leading to the surgical replacement of the valve, which completely resolved the problem. This case points out that, although rare, in infectious endocarditis due to Staphylococcus capitis its pathogenicity is significant.


Assuntos
Bioprótese/efeitos adversos , Endocardite Bacteriana/etiologia , Próteses Valvulares Cardíacas/efeitos adversos , Infecções Relacionadas à Prótese/etiologia , Infecções Estafilocócicas/etiologia , Valva Aórtica , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Valva Mitral , Infecções Relacionadas à Prótese/diagnóstico , Infecções Relacionadas à Prótese/cirurgia , Reoperação , Infecções Estafilocócicas/diagnóstico , Infecções Estafilocócicas/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA